Lead toxicity part II: The role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity

Alternative Medicine Review

Volumn 11, Issue 2, 2006, Pages 114-127

  Patrick, Lyn ^a,b,c  

^a Southwest College of Naturopathic Medicine ^*  (United States)

^b Southwestern College   (United States)

^c Hepatitis C Ambassadors Team   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINOLEVULINIC ACID; ANTIOXIDANT; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CHELATING AGENT; DNA; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LEAD; MALONALDEHYDE; NITRIC OXIDE; NUCLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PORPHOBILINOGEN SYNTHASE; PYRIDOXINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TAURINE; THIOCTIC ACID; THIOL DERIVATIVE; UNINDEXED DRUG; ZINC;

CELL MEMBRANE; CHELATION; DNA REPAIR; ENZYME INHIBITION; ERYTHROCYTE; HEME SYNTHESIS; HUMAN; HYPERTENSION; INFLAMMATION; LEAD BLOOD LEVEL; LEAD POISONING; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIOXIDANTS; GLUTATHIONE; HUMANS; HYPERTENSION; LEAD; LEAD POISONING; NITRIC OXIDE; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS;

EID: 33745903081     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress. Part 1. Mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001;1:529-539.
2. Vaziri ND, Ding Y, Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1999;34:558-562.
3. Meister A, Anderson MD. Glutathione. Annu Rev Biochem 1983;52;711-760.
4. Christie NT, Costa M. In vitro assessment of the toxicity of metal compounds. IV. Disposition of metals in cells: interaction with membranes, glutathione, metallothionein, and DNA. Biol Trace Elem Res 1984;6:139-158.
5. Hsu JM. Lead toxicity as related to glutathione metabolism. J Nutr 1981;111:26-33.
6. Ahamed M, Verma S, Kumar A, Siddiqui MK. Environmental exposure to lead and its correlation with biochemical indices in children. Sci Total Environ 2005;346:48-55.
7. Garcon G, Leleu B, Zerimech F, et al. Biologic markers of oxidative stress and nephrotoxicity as studied in biomonitoring of adverse effects of occupational exposure to lead and cadmium. J Occup Environ Med 2004;46:1180-1186.
8. Hunaiti A, Soud M, Khalil A. Lead concentration and the level of glutathione, glutathione S-transferase, reductase and peroxidase in the blood of some occupational workers from Irbid City, Jordan. Sci Total Environ 1995;170:95-100.
9. Lachant NA, Tomoda A, Tanaka KR. Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning. Blood 1984;63:518-524.
10. Farant JP, Wigfield DC. Biomonitoring lead exposure with delta-aminolevulinate dehydratase (ALA-D) activity ratios. Int Arch Occup Environ Health 1982;51:15-24.
11. Sandhir R, Julka D, Gill KD. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol Toxicol 1994;74:66-71.
12. Gurer-Orhan H, Sabir HU, Ozgunes H. Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers. Toxicology 2004;195:147-154.
13. Yiin SJ, Lin TH. Lead-catalyzed peroxidation of essential unsaturated fatty acid. Biol Trace Elem Res 1995;50:167-172.
14. Bechara EJ. Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid. Braz J Med Biol Res 1996;29:841-851.
15. Lawton LJ, Donaldson WE. Lead-induced tissue fatty acid alterations and lipid peroxidation. Biol Trace Elem Res 1991;28:83-97.
16. Shafiq-ur-Rehman S, Abdulla M. Impact of lead on phospholipid metabolism in human erythrocyte membranes. Bull J Toxicol Occup Environ Health 1993;2:35.
17. Flora GJ, Seth PK. Alterations in some membrane properties in rat brain following exposure to lead. Cytobios 2000;103:103-109.
18. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000;29:927-945.
19. Ribarov SR, Benov LC. Relationship between the hemolytic action of heavy metals and lipid peroxidation. Biochim Biophys Acta 1981;640:721-726.
20. Hiraku Y, Kawanishi S. Mechanism of oxidative DNA damage induced by delta-aminolevulinic acid in the presence of copper ion. Cancer Res 1996;56:1786-1793.
21. Sugawara E, Nakamura K, Miyake T, et al. Lipid peroxidation and concentration of glutathione in erythrocytes from workers exposed to lead. Br J Ind Med 1991;48:239-242.
22. Chiba M, Shinohara A, Matsushita K, et al. Indices of lead-exposure in blood and urine of lead-exposed workers and concentrations of major and trace elements and activities of SOD, GSH-Px and catalase in their blood. Tohoku J Exp Med 1996;178:49-62.
23. Han SG, Kim Y, Kashon ML, et al. Correlates of oxidative stress and free-radical activity in serum from asymptomatic shipyard welders. Am J Respir Crit Care Med 2005;172:1541-1548.
24. Kasperczyk S, Kasperczyk A, Ostalowska A, et al. Activity of glutathione peroxidase, glutathione reductase, and lipid peroxidation in erythrocytes in workers exposed to lead. Biol Trace Elem Res 2004;102:61-72.
25. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for lead. (Draft for Public Comment). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 2005:43-59.
26. Staessen JA, Roels H, Lauwerys RR, Amery A. Low-level lead exposure and blood pressure. J Hum Hypertens 1995;9:303-328.
27. Vaziri ND, Sica DA. Lead-induced hypertension: role of oxidative stress. Curr Hypertens Rep 2004;6:314-320.
28. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142-146.
29. Vaziri ND, Ding Y, Ni Z, Gonick HC. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy. Kidney Int 1997;52:1042-1046.
30. Roberts CK, Vaziri ND, Liang KH, Barnard RJ. Reversibility of chronic experimental syndrome X by diet modification. Hypertension 2001;37:1323-1328.
31. Roggensack AM, Zhang Y, Davidge ST. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999;33:83-89.
32. Swei A, Lacy F, DeLano FA, Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 1997;30:1628-1633.
33. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998;53:1748-1754.
34. Tse WY, Maxwell SR, Thomason H, et al. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens 1994;8:843-849.
35. Lacy F, O'Conner DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998;16:291-303.
36. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993;19:59-66.
37. Boger RH, Ron ES. L-arginine improves vascular function by overcoming the deleterious effects of ADMA, a novel cardiovascular risk factor. Altern Med Rev 2005;10:14-23.
38. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrate formation in vivo? FEBS Lett 1997;411:157-160.
39. Tsao DA, Yu HS, Cheng JT, et al. The change of beta-adrenergic system in lead-induced hypertension. Toxicol Appl Pharmacol 2000;164:127-133.
40. Chang HR, Chen SS, Chen TJ, et al. Lymphocyte beta2-adrenergic receptors and plasma catecholamine levels in lead-exposed workers. Toxicol Appl Pharmacol 1996;139:1-5.
41. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 2001;298:679-685.
42. Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology 2002;180:33-44.
43. Levin SM, Goldberg M. Clinical evaluation and management of lead-exposed construction workers. Am J Ind Med 2000;37:23-43.
44. Hsu PC, Liu MY, Hsu CC, et al. Lead exposure causes generation of reactive oxygen species and functional impairment in rat sperm. Toxicology 1997;122:133-143.
45. Patra RC, Swarup D, Dwivedi SK. Antioxidant effects of alpha tocopherol, ascorbic acid, and L-methionine on lead-induced oxidative stress to the liver, kidney and brain in rats. Toxicology 2001;162:81-88.
46. Hsu PC, Hsu CC, Liu MY, et al. Lead-induced changes in spermatozoa function and metabolism. J Toxicol Environ Health A 1998;55:45-64.
47. Vij AG, Satija NK, Flora SJ. Lead induced disorders in hematopoietic and drug metabolizing enzyme system and their protection by ascorbic acid supplementation. Biomed Environ Sci 1998;11:7-14.
48. Dalley JW, Gupta PK, Hung CT. A physiological pharmacokinetic model describing the disposition of lead in the absence and presence of L-ascorbic acid in rats. Toxicol Lett 1990;50:337-348.
49. West WL, Knight EM, Edwards CH, et al. Maternal low level lead and pregnancy outcomes. J Nutr 1994;124:981S-986S.
50. Tandon SK, Chatterjee M, Bhargava A, et al. Lead poisoning in Indian silver refiners. Sci Total Environ 2001;281:177-182.
51. Lauwerys R, Roels H, Buchet JP, et al. The influence of orally-administered vitamin C or zinc on the absorption of and biological response to lead. J Occup Med 1983;25:668-678.
52. Suzuki T, Yoshida A. Effectiveness of dietary iron and ascorbic acid in the prevention and cure of moderately long-term lead toxicity in rats. J Nutr 1979;109:1974-1978.
53. Dawson EB, Evans DR, Harris WA, et al. The effect of ascorbic acid supplementation on the blood lead level of smokers. J Am Coll Nutr 1999;18:166-170.
54. Fischer AB, Hess C, Neubauer T, Eikmann T. Testing of chelating agents and vitamins against lead toxicity using mammalian cell cultures. Analyst 1998;123:55-58.
55. Shalan MG, Mostafa MS, Hassouna MM, et al. Amelioration of lead toxicity on rat liver with vitamin C and silymarin supplements. Toxicology 2005;206:1-15.
56. Simon JA, Hudes ES. Relationship of ascorbic acid to blood lead levels. JAMA 1999;281:2289-2293.
57. Lee DH, Lim JS, Song K, et al. Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U.S. population: results from the Third National Health and Nutrition Examination Survey. Environ Health Perspect 2006;114:350-354.
58. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004;38:535-539.
59. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327-330.
60. Lim JS, Yang JH, Chun BY, et al. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004;37:1018-1023.
61. Patrick L. Lead toxicity, a review of the literature. Part I. Exposure, evaluation, and treatment. Altern Med Rev 2006;11:2-22.
62. Levander OA, Morris VC, Ferretti RJ. Filterability of erythrocytes from vitamin E-deficient lead-poisoned rats. J Nutr 1977;107:363-372.
63. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr 1991;53:1050S-1055S.
64. Chaurasia SS, Kar A. Protective effects of vitamin E against lead-induced deterioration of membrane associated type-1 iodothyronine 5'-monodeiodinase (5'D-I) activity in male mice. Toxicology 1997;124:203-209.
65. Reed DJ, Orrenius S. The role of methionine in glutathione biosynthesis by isolated hepatocytes. Biochem Biophys Res Commun 1977;77:1257-1264.
66. Jurczuk M, Moniuszko-Jakoniuk J, Brzoska MM. Involvement of some low-molecular thiols in the peroxidative mechanisms of lead and ethanol action on rat liver and kidney. Toxicology 2006;219:11-21.
67. Flora SJ, Singh S, Tandon SK. Thiamine and zinc in prevention or therapy of lead intoxication. J Int Med Res 1989;17:68-75.
68. Flora SJ, Kumar D, Das Gupta S. Interaction of zinc, methionine or their combination with lead at gastrointestinal or post-absorptive level in rats. Pharmacol Toxicol 1991;68:3-7.
69. Ercal N, Treeratphan P, Hammond TC, et al. In vivo indices of oxidative stress in lead-exposed C57BL/6 mice are reduced by treatment with meso2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radic Biol Med 1996;21:157-161.
70. Neal R, Yang P, Fiechtl J, et al. Pro-oxidant effects of delta-aminolevulinic acid (delta-ALA) on Chinese hamster ovary (CHO) cells. Toxicol Lett 1997;91:169-178.
71. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-250.
72. Sivaprasad R, Nagaraj M, Varalakshmi P. Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney. Arch Toxicol 2002;76:437-441.
73. Pande M, Flora SJ. Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology 2002;177:187-196.
74. Flora SJ, Jain VK, Behari JR, Tandon SK. Protective role of trace metals in lead intoxication. Toxicol Lett 1982;13:52-56.
75. Batra N, Nehru B, Bansal MP. The effect of zinc supplementation on the effects of lead in the rat testis. Reprod Toxicol 1998;12:535-540.
76. Ryan-Harshman M, Aldoori W. The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Can J Diet Pract Res 2005;66:98-102.
77. Othman AI, El Missiry MA. The role of selenium against lead toxicity in male rats. J Biochem Mol Toxicol 1998;12:345-349.
78. Tandon SK, Flora SJ, Singh S. Influence of pyridoxine (vitamin B6) on lead intoxication in rats. Ind Health 1987;25:93-96.
79. McGowan C. Influence of vitamin B6 status on aspects of lead poisoning in rats. Toxicol Lett 1989;47:87-93.
80. Wright CE, Tallan HH, Lin YY, Gaull GE. Taurine: biological update. Annu Rev Biochem 1986;55:427-453.
81. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta 2006;366:190-195.
82. Oriyanhan W, Yamazaki K, Miwa S, et al. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 2005;20:278-285.
83. Gurer H, Ozgunes H, Neal R, et al. Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 1998;128:181-189.
84. Flora SJ, Pande M, Kannan GM, Mehta A. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol (Noisy-le-grand) 2004;50:OL543-OL551.
85. Flora SJ, Pande M, Mehta A. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 2003;145:267-280.
86. Sivaprasad R, Nagaraj M, Varalakshmi P. Combined efficacies of lipoic acid and 2,3-dimercaptosuccinic acid against lead-induced lipid peroxidation in rat liver. J Nutr Biochem 2004;15:18-23.
87. Flora SJ, Bhattacharya R, Sachan SR. Dose-dependant effects of zinc supplementation during chelation of lead in rats. Pharmacol Toxicol 1994;74:330-333.